Five minutes with… Jacqueline Mulryne


Muireann Bolger

Five minutes with… Jacqueline Mulryne

Amid the unprecedented challenges presented by COVID-19, questions around the use of second medical use (SMU) patents have become increasingly pertinent. On Tuesday December 1, LSPN Connects session: Addressing Second Medical Use Infringement: An Evaluation of Recent SMU Cases will examine a number of key issues relating to this pivotal area of life sciences IP.

LSPN Connect, COVID-19, second medical use, life sciences, infringement, Arnold Porter, Three New Square Intellectual Property, Pfizer, Smart & Biggar